| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CYTOGFR.2014.07.018 |
| P698 | PubMed publication ID | 25200249 |
| P2093 | author name string | Laszlo Radvanyi | |
| Geok Choo Sim | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 377-390 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | The IL-2 cytokine family in cancer immunotherapy | |
| P478 | volume | 25 |
| Q47818134 | A monoclonal antibody for detection of intracellular and secreted interleukin-2 in horses |
| Q42657781 | A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma. |
| Q48119165 | An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. |
| Q100429963 | Augmentation of NK Cell Proliferation and Anti-tumor Immunity by Transgenic Expression of Receptors for EPO or TPO |
| Q90410800 | Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment |
| Q55316979 | Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation. |
| Q38848213 | Biological Response Modifier in Cancer Immunotherapy |
| Q48185876 | CD4 and CD8 T lymphocyte interplay in controlling tumor growth |
| Q89910578 | Caffeine and its main targets of colorectal cancer |
| Q33589381 | Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice |
| Q36455872 | Common gamma chain cytokines in combinatorial immune strategies against cancer |
| Q36436914 | Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models |
| Q89062087 | Cytokines in the Treatment of Cancer |
| Q41667279 | Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2. |
| Q40086298 | Developmental and Functional Control of Natural Killer Cells by Cytokines |
| Q89032225 | Driving cars to the clinic for solid tumors |
| Q40645100 | Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. |
| Q60934565 | Effect of Natural Compounds on NK Cell Activation |
| Q95841006 | Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity |
| Q92376125 | Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy |
| Q91990544 | Ginsenosides from Korean red ginseng modulate T cell function via the regulation of NF-AT-mediated IL-2 production |
| Q35918321 | IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection |
| Q50004232 | IL-2 and Beyond in Cancer Immunotherapy |
| Q47563691 | IL-2 mediates NK cell proliferation but not hyperactivity |
| Q36024656 | Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure). |
| Q38836832 | Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| Q35652772 | Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma |
| Q55034487 | Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients. |
| Q93018628 | Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma |
| Q45317122 | Interleukin-2 family signaling |
| Q89229413 | Isoflurane decreases interleukin-2 production by increasing c-Cbl and Cbl-b expression in rat peripheral blood mononuclear cells |
| Q58080330 | Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression |
| Q47137850 | Manipulation of Innate Immunity for Cancer Therapy in Dogs. |
| Q50094781 | Migrating into the Tumor: a Roadmap for T Cells |
| Q33873731 | Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy. |
| Q57148008 | Modulation of intracellular calcium signaling by microRNA-34a-5p |
| Q89510977 | NK Cell-Based Immunotherapy in Renal Cell Carcinoma |
| Q40852288 | NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. |
| Q37372247 | Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes. |
| Q64249459 | Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors |
| Q37690959 | Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways |
| Q55100965 | Prospects of IL-2 in Cancer Immunotherapy. |
| Q64927862 | Radiotherapy in Combination With Cytokine Treatment. |
| Q37079072 | Role of IL-2 in cancer immunotherapy |
| Q49790787 | Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. |
| Q37113485 | Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer |
| Q50988785 | Therapeutic cancer vaccines. |
| Q90094371 | Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity |
| Q40937846 | Trans-presentation of IL-15 modulates STAT5 activation and Bcl-6 expression in TH1 cells |
| Q41933660 | Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer |
| Q41716360 | Tumor-related interleukins: old validated targets for new anti-cancer drug development |
| Q89468280 | Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo |
| Q64083291 | Unusual melanoma of the scalp with blue nevus-like features and local metastasis: A case report |
| Q38781475 | Virus-Like Particles Displaying Recombinant Short-Chain Fragment Region and Interleukin 2 for Targeting Colon Cancer Tumors and Attracting Macrophages |
| Q59358702 | [Immunotherapy - The New Era of Oncology] |
Search more.